vs
Side-by-side financial comparison of Citi Trends Inc (CTRN) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Citi Trends Inc is the larger business by last-quarter revenue ($197.1M vs $164.7M, roughly 1.2× PTC THERAPEUTICS, INC.). Citi Trends Inc runs the higher net margin — -3.5% vs -82.0%, a 78.5% gap on every dollar of revenue. On growth, Citi Trends Inc posted the faster year-over-year revenue change (10.1% vs -22.7%). Citi Trends Inc produced more free cash flow last quarter ($767.0K vs $-36.6M). Over the past eight quarters, Citi Trends Inc's revenue compounded faster (-4.3% CAGR vs -11.5%).
Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
CTRN vs PTCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $197.1M | $164.7M |
| Net Profit | $-6.9M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | -3.7% | -43.3% |
| Net Margin | -3.5% | -82.0% |
| Revenue YoY | 10.1% | -22.7% |
| Net Profit YoY | 3.6% | -104.8% |
| EPS (diluted) | $-0.86 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $197.1M | $164.7M | ||
| Q3 25 | $190.8M | $211.0M | ||
| Q2 25 | $201.7M | $178.9M | ||
| Q1 25 | $211.2M | $1.2B | ||
| Q4 24 | $179.1M | $213.2M | ||
| Q3 24 | $176.6M | $196.8M | ||
| Q2 24 | $186.3M | $186.7M | ||
| Q1 24 | $215.2M | $210.1M |
| Q4 25 | $-6.9M | $-135.0M | ||
| Q3 25 | $3.8M | $15.9M | ||
| Q2 25 | $871.0K | $-64.8M | ||
| Q1 25 | $-14.2M | $866.6M | ||
| Q4 24 | $-7.2M | $-65.9M | ||
| Q3 24 | $-18.4M | $-106.7M | ||
| Q2 24 | $-3.4M | $-99.2M | ||
| Q1 24 | $3.6M | $-91.6M |
| Q4 25 | -3.7% | -43.3% | ||
| Q3 25 | 1.8% | 1.4% | ||
| Q2 25 | 0.2% | -19.5% | ||
| Q1 25 | 0.6% | 82.5% | ||
| Q4 24 | -4.9% | -76.2% | ||
| Q3 24 | -14.1% | -27.7% | ||
| Q2 24 | -3.7% | -21.5% | ||
| Q1 24 | 1.8% | -21.6% |
| Q4 25 | -3.5% | -82.0% | ||
| Q3 25 | 2.0% | 7.5% | ||
| Q2 25 | 0.4% | -36.3% | ||
| Q1 25 | -6.7% | 73.7% | ||
| Q4 24 | -4.0% | -30.9% | ||
| Q3 24 | -10.4% | -54.2% | ||
| Q2 24 | -1.8% | -53.1% | ||
| Q1 24 | 1.7% | -43.6% |
| Q4 25 | $-0.86 | $-1.63 | ||
| Q3 25 | $0.46 | $0.20 | ||
| Q2 25 | $0.11 | $-0.83 | ||
| Q1 25 | $-1.70 | $10.04 | ||
| Q4 24 | $-0.86 | $-0.85 | ||
| Q3 24 | $-2.21 | $-1.39 | ||
| Q2 24 | $-0.42 | $-1.29 | ||
| Q1 24 | $0.43 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $107.8M | $-205.3M |
| Total Assets | $464.3M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $884.8M |
| Q4 25 | $107.8M | $-205.3M | ||
| Q3 25 | $113.2M | $-155.8M | ||
| Q2 25 | $108.6M | $-206.5M | ||
| Q1 25 | $113.2M | $-185.8M | ||
| Q4 24 | $130.3M | $-1.1B | ||
| Q3 24 | $136.6M | $-1.1B | ||
| Q2 24 | $154.8M | $-980.2M | ||
| Q1 24 | $157.7M | $-893.9M |
| Q4 25 | $464.3M | $2.9B | ||
| Q3 25 | $457.4M | $2.6B | ||
| Q2 25 | $437.4M | $2.6B | ||
| Q1 25 | $462.8M | $2.7B | ||
| Q4 24 | $467.1M | $1.7B | ||
| Q3 24 | $506.7M | $1.8B | ||
| Q2 24 | $484.1M | $1.9B | ||
| Q1 24 | $518.7M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.6M | $-34.3M |
| Free Cash FlowOCF − Capex | $767.0K | $-36.6M |
| FCF MarginFCF / Revenue | 0.4% | -22.3% |
| Capex IntensityCapex / Revenue | 4.0% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $11.9M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $-34.3M | ||
| Q3 25 | $3.9M | $-66.3M | ||
| Q2 25 | $-11.0M | $-58.3M | ||
| Q1 25 | $28.5M | $870.1M | ||
| Q4 24 | $-18.4M | $-30.0M | ||
| Q3 24 | $5.6M | $-77.0M | ||
| Q2 24 | $-19.6M | $-71.5M | ||
| Q1 24 | $23.3M | $70.8M |
| Q4 25 | $767.0K | $-36.6M | ||
| Q3 25 | $-1.7M | $-69.7M | ||
| Q2 25 | $-13.1M | $-59.6M | ||
| Q1 25 | $26.0M | $868.4M | ||
| Q4 24 | $-20.4M | $-33.8M | ||
| Q3 24 | $1.7M | $-77.5M | ||
| Q2 24 | $-21.2M | $-78.8M | ||
| Q1 24 | $20.0M | $61.2M |
| Q4 25 | 0.4% | -22.3% | ||
| Q3 25 | -0.9% | -33.1% | ||
| Q2 25 | -6.5% | -33.3% | ||
| Q1 25 | 12.3% | 73.8% | ||
| Q4 24 | -11.4% | -15.8% | ||
| Q3 24 | 0.9% | -39.4% | ||
| Q2 24 | -11.4% | -42.2% | ||
| Q1 24 | 9.3% | 29.1% |
| Q4 25 | 4.0% | 1.4% | ||
| Q3 25 | 2.9% | 1.6% | ||
| Q2 25 | 1.0% | 0.7% | ||
| Q1 25 | 1.2% | 0.1% | ||
| Q4 24 | 1.1% | 1.8% | ||
| Q3 24 | 2.2% | 0.3% | ||
| Q2 24 | 0.9% | 4.0% | ||
| Q1 24 | 1.5% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | 1.01× | -4.17× | ||
| Q2 25 | -12.59× | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
